Hints and tips:
...The eye-opening numbers are the result of Bravo’s bullishness on the software sector, even as valuations skyrocket industry-wide. “We’re doing nothing different now than we used to....
...One plus point of next year’s demerger for GSK (as well as separating two businesses that appeal to very different types of investor) is to send debt with the consumer business’s cash flows....
...She didn’t overpay for the Pfizer consumer assets — and ended up doing the joint venture which was good for both parties,” he said....
...Job moves UnitedHealth Group has named former GlaxoSmithKline chief executive Andrew Witty, to succeed Dave Wichmann as chief executive after he spent less than four years in the role. More here....
...We also have a first take on gross domestic product in the eurozone and earnings reports from tech titans Amazon and Alphabet, key pharma vaccine participants Pfizer and GlaxoSmithKline, as well as Royal...
...month GlaxoSmithKline snapped another oncology-focused group, Tesaro, for $5.1bn....
...And the business is growing fast organically and by acquisition, with clearance for a £240m takeover of Hungry House. It is doing it profitably, too....
...Beecham....
...A veteran of the pharmaceuticals industry, he experienced a big merger while working for SmithKline Beecham when it combined with Glaxo Wellcome in 2000....
...In 2013, the group raised almost $4bn by listing its non-alcoholic drinks and food business, and acquired the Lucozade and Ribena brands from GlaxoSmithKline for £1.35bn....
...Forget the fact that its financial teams were doing what all such groups should do — which, among other things, is to minimise tax payments....
...It’s a fundamental change in the way business is done.” Today, Lady Geek publishes its second Empathy Index....
...He notes that Allergan was spun out of SmithKline in 1989 when it merged with Beecham....
...Christopher Adams Earnings BP Q2 $0.09 ($0.20) ● GlaxoSmithKline is expected to announce another drop in quarterly profits as its troubled respiratory drugs business continues to struggle....
...Megamergers such as Pfizer’s $90bn takeover of Warner-Lambert in 1999 and SmithKline’s $72bn merger with Glaxo had struggled to produce growth....
...But some academics believe that in doing so, the research missed the full scope of business social activity....
...The Queen’s horse Estimate, former Gold Cup champion, has failed a drug test, as has GlaxoSmithKline....
...A chartered accountant, he joined SmithKline, a predecessor company of GSK, in 1989....
...In doing that, Metcalfe’s is copying a strategy pursued by other popular chains such as Starbucks, PizzaExpress and Nando’s....
...It is widely accepted that lawyers working inside a company will reflect that company’s culture and way of doing business....
...companies doing business in China....
...As big business stakes claims to being more charitable, charities are becoming more business-minded – and employing rather uncharitable language to whip multinationals into shape....
...Look at the portfolios of demography funds and holdings such as Norwegian Cruise Line are as likely as GlaxoSmithKline. But understanding ageing economies is not enough....
...Mr Getnick argues that fines may end up “being incorporated as a cost of doing business”, which could lead prosecutors to conclude that criminal action against corporate executives is the next step....
...“While a medical scientist can learn the business end, as I did at Merck, a non-technical person can learn enough about the technology to lead a company very well.”...
International Edition